Sep 15, 2022 09:15AM
Sep 15, 2022 09:15AM
Sep 15, 2022 09:15AM
Aug 4, 2022 04:05PM
Aug 4, 2022 04:05PM
May 23, 2022 04:05PM
May 23, 2022 04:05PM Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
May 23, 2022 04:05PM
Nov 4, 2021 04:05PM
Nov 4, 2021 04:05PM
Sep 1, 2021 08:00AM
Sep 1, 2021 08:00AM
Aug 5, 2021 04:05PM
Aug 5, 2021 04:05PM Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 29, 2021 08:00AM
Jul 29, 2021 08:00AM
Jul 22, 2021 08:00AM
Jul 22, 2021 08:00AM
Jun 22, 2021 08:00AM
Jun 22, 2021 08:00AM
Jun 17, 2021 08:00AM Caladrius Biosciences to Present at Noble Capital Markets Virtual Investor Forum during the 16th Annual World Stem Cell Summit
Jun 17, 2021 08:00AM
Jun 1, 2021 08:30AM
Jun 1, 2021 08:30AM
May 12, 2021 08:00AM
May 12, 2021 08:00AM
May 6, 2021 04:05PM
May 6, 2021 04:05PM Caladrius Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
May 4, 2021 09:00AM
May 4, 2021 09:00AM
Apr 29, 2021 08:30AM
Apr 29, 2021 08:30AM
Mar 8, 2021 08:03AM
Mar 8, 2021 08:00AM
Mar 8, 2021 08:00AM Caladrius Biosciences Announces Orphan Drug Designation for CLBS12 for the Treatment of Buerger’s Disease
Mar 3, 2021 08:30AM
Mar 3, 2021 08:30AM
Feb 25, 2021 04:05PM
Feb 25, 2021 04:05PM
Feb 18, 2021 04:05PM
Feb 18, 2021 04:05PM
Feb 17, 2021 01:59PM Caladrius Biosciences, Inc. Closes $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
Feb 17, 2021 01:59PM
Feb 12, 2021 08:16AM
Feb 12, 2021 08:15AM
Feb 12, 2021 08:15AM
Jan 25, 2021 05:04PM
Jan 25, 2021 05:04PM
Jan 25, 2021 08:30AM Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021
Jan 25, 2021 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All